Handelsbanken Fonder AB’s Edwards Lifesciences Corp Position
Does Handelsbanken Fonder AB own Edwards Lifesciences Corp (EW)? Yes — 1.26M shares worth $101M (+0.34% of its 13F portfolio) as of Q1 2026, up from 1.20M shares the prior filed quarter.
Position Value
$101M
Q1 2026
Shares
1.26M
% of Portfolio
+0.34%
Quarters Held
25
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.26M | $101M | +0.34% |
| Q4 2025 | 1.20M | $103M | +0.31% |
| Q3 2025 | 363.0K | $28M | +0.09% |
| Q2 2025 | 364.3K | $28M | +0.10% |
| Q1 2025 | 224.4K | $16M | +0.07% |
| Q4 2024 | 490.2K | $36M | +0.14% |
| Q3 2024 | 1.13M | $75M | +0.30% |
| Q2 2024 | 1.87M | $173M | +0.75% |
| Q1 2024 | 1.58M | $151M | +0.65% |
| Q4 2023 | 1.61M | $123M | +0.60% |
| Q3 2023 | 1.32M | $92M | +0.51% |
| Q2 2023 | 1.15M | $109M | +0.58% |
| Q1 2023 | 515.5K | $43M | +0.25% |
| Q4 2022 | 544.2K | $41M | +0.25% |
| Q3 2022 | 638.4K | $53M | +0.35% |
| Q2 2022 | 554.9K | $53M | +0.34% |
| Q1 2022 | 532.6K | $63M | +0.35% |
| Q4 2021 | 519.8K | $67M | +0.33% |
| Q3 2021 | 522.6K | $59M | +0.31% |
| Q2 2021 | 504.2K | $52M | +0.27% |
| Q1 2021 | 414.9K | $35M | +0.20% |
| Q4 2020 | 403.1K | $37M | +0.22% |
| Q3 2020 | 471.5K | $38M | +0.28% |
| Q2 2020 | 908.3K | $63M | +0.27% |
| Q1 2019 | 68.0K | $13M | +0.25% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of EW.